ClinConnect ClinConnect Logo
Search / Trial NCT05593887

Late-presenting Hip Dislocation in Non-ambulatory Children With Cerebral Palsy: A Comparison of Three Procedures

Launched by MUHAMMAD AYOUB · Oct 22, 2022

Trial Information

Current as of October 04, 2025

Recruiting

Keywords

Cerebral Palsy Mc Hale Dislocated Hip Gmfcs Iv Gmfcs V Hip Reconstruction Surgery Hrs Proximal Femoral Resection Valgus Osteotomy

ClinConnect Summary

This clinical trial is studying the best surgical options for children with cerebral palsy who have a dislocated hip and are unable to walk. Researchers want to compare three different procedures: one that aims to reconstruct the hip joint, one that focuses on relieving pain and improving function, and another that involves changing the angle of the thigh bone to help with sitting and balance. The goal is to see which procedure works best and has fewer complications for these children.

To participate in this study, children need to have a dislocated hip that has not been treated before and must be classified as non-ambulatory, meaning they cannot walk (specifically, those in levels IV and V of the Gross Motor Function Classification System). Participants will be monitored after their surgery to assess pain relief and improvements in their ability to sit and move comfortably. This trial is important because it aims to provide clearer guidance on how to best help children with this challenging condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Lesion: neglected deformed dislocated hip (Deformed head Group B, C, and D according to Rutz classification modified from MCPHCS )
  • Non-ambulatory: as defined by GMFCS level IV and V
  • Exclusion Criteria:
  • Ambulatory patients
  • patients underwent any previous hip bony procedures.
  • Non-deformed Femoral head Group A according to Rutz classification
  • Neuromuscular hip dislocation other than cp.

About Muhammad Ayoub

Muhammad Ayoub is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ensuring compliance with regulatory standards and ethical practices, Ayoub oversees the development and execution of clinical trials across various therapeutic areas. Leveraging extensive expertise in clinical operations and collaboration with leading healthcare professionals, the organization aims to contribute meaningful insights to the medical community while prioritizing participant safety and data integrity.

Locations

Cairo, Abbasia, Egypt

Patients applied

0 patients applied

Trial Officials

Mootaz Thakeb, MD

Study Chair

Ain Shams University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials